Document is current
Any future updates will be listed below
-
Authors
Riedl, Sophie
Birner, Klaudia
Schmidt-Erfurth, Ursula
-
Funding
Funding for this research was provided by:
Medical University of Vienna
- License Information
-
More Information
Article History
Received: 6 July 2024
Accepted: 18 December 2024
First Online: 24 February 2025
Conflict of interest
: S. Riedl and K. Birner declare that they have no competing interests. U. Schmidt-Erfurth: Contract Research/Grants: Apellis, Genentech, Heidelberg Engineering, Kodiak, Novartis, RetInSight, Roche; Consulting fees: AbbVie, ADARx, Alcon, Alkeus, Allergan, Annexon, Apellis, Astellas, Aviceda, Bayer, Boehringer Ingelheim, Complement Therapeutics, EcoR1, Janssen, Kodiak, Medscape, Novartis, ONL, Roche; Travel: AbbVie, Alcon, Apellis; Advisory boards: AbbVie, ADARx, Alcon, Alkeus, Apellis, Astellas, Aviceda.
